Sojournix is a biotechnology company developing medicines for women's health and neuroendocrine disorders. The Company is currently focused on the development of SJX-653, a novel, potent, and selective neurokinin-3 antagonist as a treatment for moderate to severe vasomotor symptoms due to menopause.
|HQ||Waltham, MA, US||Map|
Sojournix total Funding
Sojournix latest funding size
Time since last funding
|3 years ago|
|RA Capital Management, Boxer Capital, Frazier Healthcare Partners, Janus Henderson Investors, Venrock Healthcare Partners|
When was Sojournix founded?
Sojournix was founded in 2016.
Who are Sojournix competitors?
Competitors of Sojournix include Gennev, XL-protein and Asterion.
Where is Sojournix headquarters?
Sojournix headquarters is located at 400 Totten Pond Rd #110, Waltham.
Where are Sojournix offices?
Sojournix has an office in Waltham.
How many offices does Sojournix have?
Sojournix has 1 office.
Receive alerts for 300+ data fields across thousands of companies